6,11-4-carbon bridged erythromycin derivatives

   
   

Novel 6,11-4-carbon bridged erythromycin derivatives and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are methods for treating bacterial infections by administering to an animal a pharmaceutical composition containing a therapeutically effective amount of a compound of the invention and processes for the preparation of such compounds.

 
Web www.patentalert.com

< Method of treating lower urinary tract disorders

< Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage

> Electromagnetophoretic display system and method

> Methods for prevention and treatment of gastrointestinal disorders

~ 00117